Erica Browne to Adult
This is a "connection" page, showing publications Erica Browne has written about Adult.
Connection Strength
1.201
-
Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health. 2023 02 10; 23(1):58.
Score: 0.151
-
Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451.
Score: 0.125
-
A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis. Ophthalmic Epidemiol. 2017 02; 24(1):63-70.
Score: 0.099
-
Measuring Pre-Exposure Prophylaxis (PrEP) Stigma Among Adolescent Girls and Young Women in Western Kenya: Scale Development, Validation, and Associations with PrEP Adherence. AIDS Patient Care STDS. 2025 Aug; 39(8):323-338.
Score: 0.045
-
Longer-acting preexposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment. AIDS. 2025 Aug 01; 39(10):1364-1374.
Score: 0.044
-
PrEP knowledge, attitudes, and perceived barriers to access among American Indian/Alaska Native people in the US: Results from an online survey. PLoS One. 2025; 20(4):e0321422.
Score: 0.044
-
Greater Improvements in Vaccination Outcomes Among Black Young Adults With Vaccine-Resistant Attitudes in the United States South Following a Digital Health Intervention: Latent Profile Analysis of a Randomized Control Trial. JMIR Public Health Surveill. 2025 Apr 16; 11:e67370.
Score: 0.044
-
Ecological momentary assessment study of same-hour polysubstance use among people who use opioids and additional substances. Drug Alcohol Depend. 2025 Apr 01; 269:112582.
Score: 0.043
-
Criminal legal system engagement among people who use drugs in Oregon following decriminalization of drug possession. Drug Alcohol Depend. 2024 Nov 01; 264:112449.
Score: 0.042
-
We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024; 19(8):e0308577.
Score: 0.042
-
"My Family Was Also Happy": Couples' Qualitative Reports of a Combined Behavioral Economics and Cognitive Behavioral Therapy Intervention to Reduce Alcohol Use and Intimate Partner Violence. Violence Against Women. 2024 Sep; 30(11):2901-2916.
Score: 0.038
-
Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama. Vaccine. 2022 11 15; 40(48):6908-6916.
Score: 0.037
-
Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. PLoS One. 2022; 17(2):e0263664.
Score: 0.035
-
The Role of Families in Adolescent and Young Adults' PrEP Use. AIDS Behav. 2022 May; 26(5):1618-1632.
Score: 0.035
-
Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020 Feb; 24(2):617-628.
Score: 0.031
-
Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S222-S229.
Score: 0.030
-
First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):304-310.
Score: 0.029
-
Time Trade-off Utility Values in Noninfectious?Uveitis. Am J Ophthalmol. 2019 12; 208:47-55.
Score: 0.029
-
End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283.
Score: 0.029
-
Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019 04 01; 80(4):394-403.
Score: 0.029
-
Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addict Behav. 2018 10; 85:94-99.
Score: 0.027
-
Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. Am J Ophthalmol. 2018 07; 191:14-22.
Score: 0.027
-
The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018 03; 21(3):e25094.
Score: 0.027
-
Distinguishing Features of Ocular Sarcoidosis in an International Cohort of Uveitis Patients. Ophthalmology. 2018 01; 125(1):119-126.
Score: 0.026
-
Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis. Am J Ophthalmol. 2017 Jul; 179:10-17.
Score: 0.025
-
Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies. Am J Ophthalmol. 2016 Aug; 168:279-286.
Score: 0.024
-
Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. Ophthalmology. 2015 Jun; 122(6):1257-61.
Score: 0.022
-
A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014 Oct; 121(10):1863-70.
Score: 0.021